Sign in
8-K

Current Report

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-25-005284

Shareholder rights changed · Bylaws or fiscal year change · Other events

  • Item 3.03 Material modification to rights of security holders
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading cns_8k.htm…